Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:54 pm Purchase | 13G | FORTE BIOSCIENCES FBRX | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,630,468 9.99% | 3,630,468 (New Position) | View |
| 2023-02-14 10:52 am Sale | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,231,427 3.9% | -396,982 (-15.10%) | View |
| 2022-05-11 4:03 pm Sale | 13D | EXICURE INC XCUR | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 5,856,310 4.77% | -393,690 (-6.30%) | View |
| 2022-03-14 09:29 am Sale | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,408,259 4.8% | -549,702 (-28.08%) | View |
| 2022-02-14 12:06 pm Sale | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 5.8% | -36,000 (-1.35%) | View |
| 2022-01-03 09:26 am Sale | 13G | TPG PACE BEN FIN CORP TPGY | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 0 0% | -4,957,302 (Position Closed) | View |
| 2021-04-09 11:50 am Purchase | 13G | TPG PACE BEN FIN CORP TPGY | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 4,957,302 14.2% | 4,957,302 (New Position) | View |
| 2021-02-16 12:09 pm Sale | 13G | FARFETCH LTD FTCH | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 5,354,942 1.8% | -12,716,435 (-70.37%) | View |
| 2020-11-12 09:11 am Unchanged | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 9.2% | 0 (Unchanged) | View |
| 2020-07-20 09:51 am Unchanged | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 10.8% | 0 (Unchanged) | View |
| 2020-05-29 09:21 am Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 7.4% | 2,664,409 (New Position) | View |
| 2020-02-14 12:07 pm Purchase | 13G | FARFETCH LTD FTCH | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 18,071,377 7% | 18,071,377 (New Position) | View |
| 2019-08-12 4:05 pm Purchase | 13D | EXICURE INC XCUR | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 6,250,000 8.23% | 6,250,000 (New Position) | View |
| 2019-06-03 4:03 pm Purchase | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 11.06% | 1,957,961 (New Position) | View |